✦ LIBER ✦

Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease

✍ Scribed by Randall J. Bateman; William E. Klunk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Translational medicine perspective in de

✍ Hong I. Wan; Orest Hurko; Mark Day; J. Lynn Rutkowski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Antiglutamatergic therapy in Alzheimer's

✍ S. Tekin; C. Aykut-Bingöl; T. Tanrıdağ; S. Aktan 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 147 KB

The effects of group work therapy in pat

✍ Junichi Ishizaki; Kenichi Meguro; Hiroshi Ishii; Satoshi Yamaguchi; Masumi Shima 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 3 views

BACE: Lead Target for Orchestrated Thera

✍ Dr. Andrew Stamford 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Effects of oral physostigmine in Alzheim

✍ Dr Yaakov Stern; Mary Sano; Richard Mayeux 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Cognitive evaluation of disease-modifyin

✍ Debby Van Dam; Katrien Coen; Peter Paul De Deyn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 159 KB